Summerville facility treated two patients with recalled NECC drug

FILE- This undated file image made available by The Centers for Disease Control and Prevention shows the Exserohilum rostratum fungus.There are numerous ways a fungus might contaminate medications being made in a lab. (AP Photo/The Centers for Disease Control, File)

Another Charleston-area healthcare facility has been identified as having treated patients with one of the hundreds of recalled drugs made by the New England Compounding Center, the firm at the center of a federal investigation regarding a suspect steroid linked to an outbreak of fungal meningitis.

Lowcountry Outpatient Surgery Center of Summerville gave injections of the NECC product Isovue to two patients, said Joyce McQuiston, the center administrator.

“Luckily, we didn’t receive any of the steroids,” she said.

Isovue is in a group of drugs known as contrast agents that are used to allow blood vessels, organs and other non-bony tissue to be seen more clearly on a CT scan or other radiologic examination, according to

Both patients have been contacted and advised that they received an injection of the recalled drug, McQuiston said.

On Monday, the FDA released a NECC customer list that included Lowcountry Outpatient Surgery Center. The list said the center received the recalled drug Baclofen, but McQuiston said that was not the case.

The FDA later said the list was based on incorrect information provided by NECC.

“FDA is working to correct the list and will re-post when we are sure it is accurate,” the agency said at its website.

On Tuesday, 304 cases of fungal meningitis and four joint infections thought to be linked to the injected, tainted steroid methylprednisolone acetate were reported by the Centers for Disease Control and Prevention. The fungal meningitis death toll climbed to 23. The disease is not contagious. South Carolina has not had a confirmed case of fungal meningitis linked to possibly tainted methylprednisolone acetate.